中国医药: 关于中国医药健康产业股份有限公司2025年第四次临时股东大会的法律意见书

Group 1 - The legal opinion letter confirms that the procedures for convening and holding the shareholders' meeting comply with the Company Law, Shareholders' Meeting Rules, and the company's articles of association [2][3][5] - The shareholders' meeting was scheduled for July 11, 2025, with a registration date of July 3, 2025, and utilized both a physical meeting and an online voting system [2][3] - A total of 1,213 shareholders participated in the online voting, representing 154,915,116 shares, which is 10.3561% of the total voting shares [3][4] Group 2 - The voting results showed that 152,045,883 shares were in favor of the proposals, accounting for 98.1478% of the valid votes cast [5] - Among minority investors, 12,045,883 shares voted in favor, representing 80.7629% of the valid votes from this group [5] - The legal opinion concludes that the meeting's procedures, participant qualifications, voting methods, and results are all valid and comply with relevant laws and regulations [5][6]